Randomized, Double-blind, Multi-center, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Pneumostem Versus a Control Group for Treatment of Bronchopulmonary Dysplasia in Premature Infants
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2019
Price : $35 *
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Bronchopulmonary dysplasia
- Focus Therapeutic Use
- Sponsors Medipost
- 18 Apr 2017 Status changed from active, no longer recruiting to completed.
- 08 Apr 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 03 Sep 2014 New trial record